Home » Topics » Regulatory

Regulatory
RSS

Strensiq receives first approval in Japan for hypophosphatasia

July 7, 2015

Acoalan approved in Japan

July 6, 2015

FDA grants approval to Orkambi for cystic fibrosis

July 3, 2015

FDA approves Tuxarin ER

July 3, 2015

European approval of Simponi for non-radiographic axial spondyloarthritis

June 29, 2015

Radicut approved in Japan for amyotrophic lateral sclerosis

June 29, 2015

FDA approves Rapamune for lymphangioleiomyomatosis

June 2, 2015

Empagliflozin/metformin pill approved in E.U. for type 2 diabetes

May 29, 2015

FDA approves Viberzi and Xifaxan for IBS-D

May 28, 2015

FDA first to approve tiotropium bromide/olodaterol for COPD

May 27, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...